JPRN-UMIN000013439
Recruiting
Phase 2
The efficacy and safety of concurrent chemoradiotherapy for squamous cell carcinoma of the vulva. Phase II Study - ESCCSV TRIA
TGCU(Tohoku Gynecological Cancer Unit)0 sites40 target enrollmentMarch 18, 2014
ConditionsVulva cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Vulva cancer
- Sponsor
- TGCU(Tohoku Gynecological Cancer Unit)
- Enrollment
- 40
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. History of chemotherapy or radiotherapy 2\. Active double cancer 3\. Active infection 4\. Severe complicating illness ( bronchial asthma, pneumonia, ischemic heart disease, diabetes mellitus, arrhythmia) 5\. Massive ascites or pleural fluid 6\. History of severe allergic reaction 7\. pregnant, lactating women and women who expects pregnant 8\. Difficult case to keep the regulations and observations 9\. Other reason that primary doctor think ineligible
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Efficacy and toxicity of concomitant chemoradiation with weekly gemcitabine/cisplatin in comparison with weekly cisplatin in cervical cancer: a phase II, randomised trialCervical cancer (FIGO stage IB, II , III, IVA)CancerCervical cancerISRCTN29976507Shaheed Beheshti University of Medical Science (SBMU) (Iran)80
Completed
Phase 2
Comparison of 3-weekly administration of continuous dose cisplatin with divided dose in head and neck carcinomaIRCT20201220049776N1Tehran University of Medical Sciences60
Not Yet Recruiting
Phase 2
Prospective Study of Concurrent Chemoradiotherapy with S-1 and hypofractionated radiotherapy for outpatients with early glottic squamous cell carcinomasJPRN-UMIN000023416agoya University Graduate School of Medicine, Department of Radiology40
Unknown
Phase 3
A comparison of concurrent chemo-radiotherapy plus hyperthermia versus concurrent chemo-radiotherapy in locally advanced cervical cancer patients: A randomized controlled trial-This study aim to compare concurrent chemoradiotherapy and concurrent chemoradiotherapy plus hyperthermia in locally advanced cervical cancer in term of treatment response rate.Deep regional hyperthermiaThermotron-RF8radiation therapychemotherapyTCTR20180711002Chulabhorn Hospital, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy90
Recruiting
N/A
Clinical trial of concurrent chemoradiotherapy (CCRT) with S-1 in patients with advanced head and neck squamous cell carcinoma, who is not eligible for CCRT with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) regimeadvanced head and neck squamous cell carcinomaJPRN-UMIN000021870Yokohama City University hospital40